Acetaminophen Market Snapshot (2023 to 2033)

The global acetaminophen market enjoys a valuation of US$ 9.8 Billion by the end of the year 2022 and is further set to expand at a CAGR of 4.2% to reach a valuation of US$ 15.2 Billion by the year 2033. According to a recent, study by Future Market Insights, the oral route of administration is leading the market with a share of about 92.4% in the year 2022, within the global market.

Market Outlook:

Data Points Market Insights
Market Value 2022 US$ 9.8 Billion
Market Value 2033 US$ 15.2 Billion
CAGR 2022 to 2033 4.2%
Market Share of Top 5 Countries 58.0%
Key Market Players Pfizer Inc., Sanofi, Janssen Pharmaceuticals., Bayer AG, GlaxoSmithKline plc, Bristol-Myers Squibb and Company, Teva Pharmaceutical Industries Ltd, Cardinal Health Inc., Perrigo Company., Novartis AG, Sun Pharmaceutical Industries Ltd, Abbott, Mallinckrodt Pharmaceuticals, and Procter & Gamble Company

The demand for acetaminophen is being driven by an increase in the number of people with chronic illnesses like cancer and chronic pulmonary obstructive disease (COPD). Prescription post-operative pain management drugs that are provided for the treatment of various trauma ailments that cause pain are fuelling the demand for acetaminophen.

The effectiveness of acetaminophen medication in everyday life is going to drive up market sales. All age groups, including infants and children, can safely use paracetamol when taken at the recommended dose. Additionally, it is risk-free throughout pregnancy.

The prevalence of conditions that can be treated with acetaminophen as the first line of pain relief, such as toothaches, migraines, neuralgia, sore throat, colds, the flu, backaches, dysmenorrhea, and rheumatic pain, has significantly increased in recent years. As a result, the acetaminophen market is anticipated to expand significantly during the forecast period.

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

Sales Analysis of the Acetaminophen Market from 2016 to 2022 Vs Market Outlook for 2022 to 2033

The market value for acetaminophen drugs was approximately 8.9% of the overall US$ 109.9 Billion of the global analgesics market in 2022.

The sale of acetaminophen drugs expanded at a CAGR of 2.9% from 2016 to 2022.

According to the American Cancer Society, 19.3 million people worldwide were affected by cancer in 2020. 20% to 50% of cancer patients have discomfort, according to the National Cancer Institute. 80 percent or more of cancer patients in the advanced stages experience moderate to severe pain. In large part due to the aging population, it is anticipated that there will be 21.7 million additional cancer cases worldwide by 2030.

Following the USA opioid epidemic, other nations are concentrating on implementing laws governing the prescribing of opioids. Governments in industrialized nations are encouraging physicians to recommend non-opioid analgesics, which gives businesses a chance to release cutting-edge non-opioid medications.

For Instance,

  • Eli Lily and Centrexion entered into an exclusive licensing arrangement in 2019 for the non-opioid treatment of chronic pain.
  • Purdue Pharma and Alivio collaborated to create a non-opioid painkiller in January 2019.

Physicians in North America and Western Europe prefer non-opioid medication formulations with innovative drug delivery systems over opioids.

On the other hand, the lack of commonly accessible opioid and non-opioid painkillers with novel drug delivery systems across Asia and Africa creates huge opportunities for the growth of the acetaminophen market in those regions.

Thus, the global acetaminophen market is expected to grow at a CAGR of 4.2% during the forecast period from 2023 to 2033.

What are the Key Opportunities for the Acetaminophen Drug Manufacturers?

The main drivers of demand for acetaminophen are the rising use of medications to address opioid tolerance and the overtreatment of pain in the population. Many individuals believe that a certain opioid dosage is ineffective in circumstances of extreme pain. These individuals gradually become opioid-tolerant and, in some cases, develop an addiction to these drugs because they require increasing doses of medication to manage their pain.

Therefore, one of the key possibilities for participants in the acetaminophen market is projected to be the commercialization of opioid-tolerant pharmaceuticals. Additionally, this will aid in minimizing the negative effects linked to or brought on by increased opioid drug use.

Another aspect opening up the market for expansion is the launch of innovative non-opioid analgesics. Opioids are commonly used for pain management in North America and Western Europe; however, due to rising non-medical use, governing authorities are urging doctors to prescribe non-opioid analgesics, which gives businesses a chance to introduce new non-opioid medications.

Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

What are the Factors Restraining Demand for Acetaminophen Drugs?

Physicians have decreased their prescriptions for pain management as a result of the severity of abuse of opioids and their misuse, which has affected overall sales globally.

  • In 2021, The World Health Organization (WHO) estimated that drug usage causes roughly 0.5 million deaths annually. Overdose deaths account for over 30% of these fatalities, which are caused by opioids in over 70% of cases. As a result, President Trump declared the opioid epidemic a national health emergency in the United States.

Opioid side effects that are chronically present are a significant barrier to the market's expansion.

For instance,

  • Excessive morphine use can cause severe respiratory system depression, which may potentially result in coma and eventual death. Long-term morphine use can potentially lead to physical and psychological addiction as well as immune system impairment.

Owed to these factors, the expansion of the global market is set to be impacted, over the forecast period.

Country-wise Insights

What Makes the USA a Large Market for Acetaminophen Drugs?

The USA dominates the North American region with a total market share of about 90.3% in 2022 and is expected to continue to experience the same growth throughout the forecast period.

Many cancer patients in the USA require ongoing pain management. 1,708,921 new instances of cancer were discovered in 2018, according to the Centres for Disease Control and Prevention.

Many cancer patients experience pain that painkillers cannot completely control (e.g. morphine). In short, research including cancer patients, the addition of acetaminophen (Tylenol) to opioids leads to better pain management without a rise in side effects.

Thus, a large population of cancer patients and growing pain management awareness is two major contributing elements to the USA's large market share.

What is the Outlook of China in the Acetaminophen Market?

During the forecast period, China is set to exhibit growth at a CAGR of nearly 5.3% in the global acetaminophen market. Since 1970, the average Chinese person's life expectancy has increased by 17 years. It is predicted that 28% of Chinese people would be 60 years of age or older by the year 2040.

The burden of non-communicable diseases is expanding in China along with life expectancy, necessitating ongoing pain management. Therefore, having a large geriatric population is a major factor in China's high market share in East Asia for acetaminophen.

What Makes India a Highly Lucrative Market for Acetaminophen Drugs?

India holds approximately 45.5% share of the South Asia market in 2022 and is projected to display growth at a lucrative growth during the forecast period.

The market for paracetamol is expanding as a result of the rise in chronic illnesses and ailments that require ongoing pain relief. Acetaminophen (Paracetamol) is the most popular pain reliever, and the Asia-Pacific region dominates this market due to India and China's rapid economic expansion.

Considering the fact that the demand for the medicine is expanding quickly in India, the Indian Medical Association (IMA) recently issued guidelines on the safety and efficacy of non-steroidal, anti-inflammatory drugs that provided patients and medical professionals with guidelines on medication prescribing and adoption for several ailments.

Get the data you need at a Fraction of the cost

Personalize your report by choosing insights you need
and save 40%!

Category-wise Insights

Which Product is Dominant in the Global Market?

Due to its superior efficacy and widespread availability in North America and Europe, the acetaminophen segment is set to maintain the largest market share of approximately 62.1% in 2023.

The market for paracetamol is expanding as a result of the rise in chronic illnesses and ailments that require ongoing pain relief. The market for paracetamol is currently being driven in particular by increases in healthcare expenditures and the ease of access to affordable paracetamol medications without a prescription in nations like South Africa, Brazil, and Argentina. Thus, the acetaminophen segment is driving demand within the global market.

Why is the Oral Route of Administration Most Preferred?

The oral route of administration is anticipated to hold 92.3% of the market share in 2023. When compared to injectables and other forms of delivery, the oral route of administration offers high-quality care specificity. This trend is anticipated to last the entire projected time.

Oral medicine administration is the most common approach. The oral route is the safest, most practical, and most economical way to provide medication because of its advantages, such as non-invasiveness, therapeutic response, and simplicity of medication delivery.

Why is the Demand for OTC (Over-the-counter) Acetaminophen High?

In terms of sales, the over-the-counter (OTC) sector is expected to hold 91.6% of the overall market share in 2023. The growing preference for medications that are readily available and offer immediate treatment is a major element driving up sales in this market.

Anyone can purchase over-the-counter (OTC) medications without a prescription. A few over-the-counter medications provide pain and itch relief. Some, like those for athlete's foot and tooth decay, treat or prevent diseases. Others assist in managing chronic issues including allergies and migraines. Hence the demand for over-the-counter is high.

Which is the Leading Distribution Channel?

Retail pharmacies are expected to account for 28.8% of the overall market share in 2023, segmented by distribution channel. Over the course of the assessment year, higher convenience and widespread availability at retail pharmacies are anticipated to fuel sales in this market.

As acetaminophen is used to treat fever and mild to moderate discomfort from headaches, colds and sore throats, menstrual cramps, toothaches, backaches, muscle pains, and reactions to injections, and is easily available in any retail pharmacy without prescription, the market share for retail pharmacies is high in the distribution channel category in the global market.

Competitive Landscape

Leading companies in the worldwide acetaminophen market are making investments in collaborations, partnerships, and distribution contracts to expand their reach internationally.

Because there are so many cases of untreated pain, analgesic manufacturers are concentrating on the Asia-Pacific and African regions. Due to the rising opioid misuse, the major players are also concentrating on creating drug formulations without opioids.

  • Sanofi successfully acquired Principia Biopharma Inc. in 2020 to expand its expertise in autoimmune and allergy diseases.
  • Sandoz, a division of Novartis, sold its U.S. business unit to Aurobindo Pharma in September 2018. Aurobindo Pharma was able to expand its product offering in the acetaminophen market due to this acquisition.

Similarly, recent developments related to companies manufacturing acetaminophen drugs have been tracked by the team at Future Market Insights, which are available in the full report.

Report Scope as per Acetaminophen Drugs Industry Analysis

Attribute Details
Forecast Period 2023 to 2033
Historical Data Available for 2016 to 2022
Market Analysis US$ Million for Value
Key Regions Covered North America, Latin America, Europe, South Asia, East Asia, Oceania, and Middle East & Africa
Key Countries Covered USA, Canada, Brazil, Mexico, Argentina, United Kingdom, Germany, Italy, Russia, Spain, France, BENELUX, India, Thailand, Indonesia, Malaysia, Japan, China, South Korea, Australia, New Zealand, Turkey, GCC Countries, North Africa, and South Africa
Key Market Segments Covered Product, Route of Administration, Sales, Distribution Channel, and Region
Key Companies Profiled
  • Pfizer Inc.
  • Sanofi
  • Janssen Pharmaceuticals.
  • Bayer AG
  • GlaxoSmithKline plc
  • Bristol-Myers Squibb and Company
  • Teva Pharmaceutical Industries Ltd
  • Cardinal Health Inc.
  • Perrigo Company.
  • Novartis AG
  • Sun Pharmaceutical Industries Ltd
  • Abbott
  • Mallinckrodt Pharmaceuticals
  • Procter & Gamble Company
Pricing Available upon Request

Key Market Segments Covered in Acetaminophen Drugs Industry Research

By Product:

  • Acetaminophen
  • Acetaminophen with Opioids
  • Others

By Route of Administration:

  • Oral
  • Injectable
  • Others

By Sales:

  • OTC (Over-the-counter)
  • Rx (Prescription)

By Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Drug Stores
  • E-commerce
  • Others

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East and Africa (MEA)

Frequently Asked Questions

Which industry is the key consumer of Acetaminophen?

The primary consumer for Acetaminophen is the pharmaceutical industry.

Who are the Key Acetaminophen Market Players?

Some of the key players in the Acetaminophen Market include Hikma Pharmaceuticals, Mallinckrodt, Captab biotech, Farmson Pharmaceutical Gujarat Pvt. Ltd., Granules India, SKPL, Glaxo SmithKline Pharmaceuticals Ltd., Atabay, Arika Healthcare, and Sino Chemical.

What is Current Market Valuation?

The market is estimated to secure a valuation of US$ 9.8 billion in 2023.

How Big will be the Acetaminophen Market by 2033?

The market is estimated to reach US$ 15.2 billion by 2033.

Which End-use Industry holds Lucrative Opportunities?

The pharmaceutical sector holds high revenue potential.

Table of Content

1. Executive Summary | Acetaminophen Market

    1.1. Global Market Outlook

    1.2. Demand Side Trends

    1.3. Supply Side Trends

    1.4. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

    2.3. Inclusion and Exclusions

3. Key Market Trends

    3.1. Key Trends Impacting the Market

    3.2. Form Innovation / Development Trends

4. Key Success Factors

    4.1. Disease Epidemiology

    4.2. Pipeline Assessment

    4.3. Key Strategies Adopted by Manufactures

    4.4. Novel Drug Approvals

    4.5. Patent Landscape

    4.6. Regulatory Scenario

    4.7. PESTEL Analysis

    4.8. Porter’s Analysis.

5. Market Background

    5.1. Macro-Economic Factors

        5.1.1. Global GDP Growth Outlook

        5.1.2. Global Healthcare Industry Outlook

        5.1.3. Global Analgesics Market Overview

    5.2. Forecast Factors - Relevance & Impact

        5.2.1. Average Annual Spending on Pain Management Drugs

        5.2.2. Average Healthcare Expenditure

        5.2.3. Increasing Prevalence of Chronic and Acute Diseases

        5.2.4. Growing Number of Patients Undergoing Surgical Interventions

        5.2.5. Rising Number of Population Suffering from End-stage Diseases

        5.2.6. Per Capita Pharmaceutical Expenditure

        5.2.7. Awareness of Pain Management Drugs

        5.2.8. Favorable Reimbursement Policies

        5.2.9. Regulatory Control over Prescriptions

        5.2.10. Popularity of Generic Products

        5.2.11. Patent Expiration of Novel Pain Management Drugs (Opioids)

        5.2.12. Introduction of Novel Abuse-deterrent Pain Management Drugs

    5.3. Market Dynamics

        5.3.1. Drivers

        5.3.2. Restraints

        5.3.3. Opportunity Analysis

6. COVID19 Crisis Analysis

    6.1. 2021 Market Scenario

    6.2. COVID-19 and Impact Analysis

        6.2.1. By Product

        6.2.2. By Route of Administration

        6.2.3. By Sales

        6.2.4. By Distribution Channel

        6.2.5. By Region

7. Global Market Demand (in Value or Size in US$ Million) Analysis 2016 to 2022 and Forecast, 2023 to 2033

    7.1. Historical Market Value (US$ Million) Analysis, 2016 to 2022

    7.2. Current and Future Market Value (US$ Million) Projections, 2023 to 2033

        7.2.1. Y-o-Y Growth Trend Analysis

        7.2.2. Absolute $ Opportunity Analysis

8. Global Market Analysis 2016 to 2022 and Forecast 2023 to 2033, By Product

    8.1. Introduction / Key Findings

    8.2. Historical Market Size (US$ Million) Analysis, By Product, 2016 to 2022

    8.3. Current and Future Market Size (US$ Million) Analysis and Forecast, By Product, 2023 to 2033

        8.3.1. Acetaminophen

        8.3.2. with Opioids

        8.3.3. Others

    8.4. Market Attractiveness Analysis, By Product

9. Global Market Analysis 2016 to 2022 and Forecast 2023 to 2033, By Route of Administration

    9.1. Introduction / Key Findings

    9.2. Historical Market Size (US$ Million) Analysis, By Route of Administration, 2016 to 2022

    9.3. Current and Future Market Size (US$ Million) Analysis and Forecast, By Route of Administration, 2023 to 2033

        9.3.1. Oral

        9.3.2. Injectable

        9.3.3. Others

    9.4. Market Attractiveness Analysis, By Route of Administration

10. Global Market Analysis 2016 to 2022 and Forecast 2023 to 2033, By Sales

    10.1. Introduction / Key Findings

    10.2. Historical Market Size (US$ Million) Analysis, By Sales, 2016 to 2022

    10.3. Current and Future Market Size (US$ Million) Analysis and Forecast, By Sales, 2023 to 2033

        10.3.1. OTC (Over-the-counter)

        10.3.2. Rx (Prescription)

    10.4. Market Attractiveness Analysis, By Sales

11. Global Market Analysis 2016 to 2022 and Forecast 2023 to 2033, By Distribution Channel

    11.1. Introduction / Key Findings

    11.2. Historical Market Size (US$ Million) Analysis, By Distribution Channel, 2016 to 2022

    11.3. Current and Future Market Size (US$ Million) Analysis and Forecast, By Distribution Channel, 2023 to 2033

        11.3.1. Hospital Pharmacies

        11.3.2. Retail Pharmacies

        11.3.3. Drug Stores

        11.3.4. E-commerce

        11.3.5. Others

    11.4. Market Attractiveness Analysis, By Distribution Channel

12. Global Market Analysis 2016 to 2022 and Forecast 2023 to 2033, By Region

    12.1. Introduction

    12.2. Historical Market Size (US$ Million) Analysis by Region, 2016 to 2022

    12.3. Current and Future Market Size (US$ Million) Analysis and Forecast, By Region, 2023 to 2033

        12.3.1. North America

        12.3.2. Latin America

        12.3.3. Europe

        12.3.4. South Asia

        12.3.5. East Asia

        12.3.6. Oceania

        12.3.7. Middle East and Africa

    12.4. Market Attractiveness Analysis, By Region

13. North America Market Analysis 2016 to 2022 and Forecast 2023 to 2033

    13.1. Introduction

    13.2. Historical Market Size (US$ Million) Trend Analysis, By Market Taxonomy, 2016 to 2022

    13.3. Current and Future Market Size (US$ Million) Analysis and Forecast, By Market Taxonomy, 2023 to 2033

        13.3.1. By Country

            13.3.1.1. USA

            13.3.1.2. Canada

        13.3.2. By Product

        13.3.3. By Route of Administration

        13.3.4. By Sales

        13.3.5. By Distribution Channel

    13.4. Market Attractiveness Analysis

        13.4.1. By Country

        13.4.2. By Product

        13.4.3. By Route of Administration

        13.4.4. By Sales

        13.4.5. By Distribution Channel

    13.5. Key Market Participants - Intensity Mapping

    13.6. Drivers and Restraints - Impact Analysis

    13.7. Key Market Trends

    13.8. Country-Level Analysis & Forecast

        13.8.1. USA Market

            13.8.1.1. Introduction

            13.8.1.2. Market Analysis and Forecast by Market Taxonomy

                13.8.1.2.1. By Product

                13.8.1.2.2. By Route of Administration

                13.8.1.2.3. By Sales

                13.8.1.2.4. By Distribution Channel

        13.8.2. Canada Market

            13.8.2.1. Introduction

            13.8.2.2. Market Analysis and Forecast by Market Taxonomy

                13.8.2.2.1. By Product

                13.8.2.2.2. By Route of Administration

                13.8.2.2.3. By Sales

                13.8.2.2.4. By Distribution Channel

14. Latin America Market Analysis 2016 to 2022 and Forecast 2023 to 2033

    14.1. Introduction

    14.2. Historical Market Size (US$ Million) Trend Analysis, By Market Taxonomy, 2016 to 2022

    14.3. Current and Future Market Size (US$ Million) Analysis and Forecast, By Market Taxonomy, 2023 to 2033

        14.3.1. By Country

            14.3.1.1. Mexico

            14.3.1.2. Brazil

            14.3.1.3. Argentina

            14.3.1.4. Rest of Latin America

        14.3.2. By Product

        14.3.3. By Route of Administration

        14.3.4. By Sales

        14.3.5. By Distribution Channel

    14.4. Market Attractiveness Analysis

        14.4.1. By Country

        14.4.2. By Product

        14.4.3. By Route of Administration

        14.4.4. By Sales

        14.4.5. By Distribution Channel

    14.5. Key Market Participants - Intensity Mapping

    14.6. Drivers and Restraints - Impact Analysis

    14.7. Key Market Trends

    14.8. Country-Level Analysis & Forecast

        14.8.1. Mexico Market

            14.8.1.1. Introduction

            14.8.1.2. Market Analysis and Forecast by Market Taxonomy

                14.8.1.2.1. By Product

                14.8.1.2.2. By Route of Administration

                14.8.1.2.3. By Sales

                14.8.1.2.4. By Distribution Channel

        14.8.2. Brazil Surgical Imaging Market

            14.8.2.1. Introduction

            14.8.2.2. Market Analysis and Forecast by Market Taxonomy

                14.8.2.2.1. By Product

                14.8.2.2.2. By Route of Administration

                14.8.2.2.3. By Sales

                14.8.2.2.4. By Distribution Channel

        14.8.3. Argentina Market

            14.8.3.1. Introduction

            14.8.3.2. Market Analysis and Forecast by Market Taxonomy

                14.8.3.2.1. By Product

                14.8.3.2.2. By Route of Administration

                14.8.3.2.3. By Sales

                14.8.3.2.4. By Distribution Channel

15. Europe Market Analysis 2016 to 2022 and Forecast 2023 to 2033

    15.1. Introduction

    15.2. Historical Market Size (US$ Million) Trend Analysis, By Market Taxonomy, 2016 to 2022

    15.3. Current and Future Market Size (US$ Million) Analysis and Forecast, By Market Taxonomy, 2023 to 2033

        15.3.1. By Country

            15.3.1.1. United Kingdom

            15.3.1.2. Germany

            15.3.1.3. Italy

            15.3.1.4. France

            15.3.1.5. Spain

            15.3.1.6. Russia

            15.3.1.7. BENELUX

            15.3.1.8. Rest of Europe

        15.3.2. By Product

        15.3.3. By Route of Administration

        15.3.4. By Sales

        15.3.5. By Distribution Channel

    15.4. Market Attractiveness Analysis

        15.4.1. By Country

        15.4.2. By Product

        15.4.3. By Route of Administration

        15.4.4. By Sales

        15.4.5. By Distribution Channel

    15.5. Key Market Participants - Intensity Mapping

    15.6. Drivers and Restraints - Impact Analysis

    15.7. Key Market Trends

    15.8. Country-Level Analysis & Forecast

        15.8.1. UK Market

            15.8.1.1. Introduction

            15.8.1.2. Market Analysis and Forecast by Market Taxonomy

                15.8.1.2.1. By Product

                15.8.1.2.2. By Route of Administration

                15.8.1.2.3. By Sales

                15.8.1.2.4. By Distribution Channel

        15.8.2. Germany Market

            15.8.2.1. Introduction

            15.8.2.2. Market Analysis and Forecast by Market Taxonomy

                15.8.2.2.1. By Product

                15.8.2.2.2. By Route of Administration

                15.8.2.2.3. By Sales

                15.8.2.2.4. By Distribution Channel

        15.8.3. Italy Market

            15.8.3.1. Introduction

            15.8.3.2. Market Analysis and Forecast by Market Taxonomy

                15.8.3.2.1. By Product

                15.8.3.2.2. By Route of Administration

                15.8.3.2.3. By Sales

                15.8.3.2.4. By Distribution Channel

        15.8.4. France Market

            15.8.4.1. Introduction

            15.8.4.2. Market Analysis and Forecast by Market Taxonomy

                15.8.4.2.1. By Product

                15.8.4.2.2. By Route of Administration

                15.8.4.2.3. By Sales

                15.8.4.2.4. By Distribution Channel

        15.8.5. Spain Market

            15.8.5.1. Introduction

            15.8.5.2. Market Analysis and Forecast by Market Taxonomy

                15.8.5.2.1. By Product

                15.8.5.2.2. By Route of Administration

                15.8.5.2.3. By Sales

                15.8.5.2.4. By Distribution Channel

        15.8.6. Russia Market

            15.8.6.1. Introduction

            15.8.6.2. Market Analysis and Forecast by Market Taxonomy

                15.8.6.2.1. By Product

                15.8.6.2.2. By Route of Administration

                15.8.6.2.3. By Sales

                15.8.6.2.4. By Distribution Channel

        15.8.7. BENULUX Market

            15.8.7.1. Introduction

            15.8.7.2. Market Analysis and Forecast by Market Taxonomy

                15.8.7.2.1. By Product

                15.8.7.2.2. By Route of Administration

                15.8.7.2.3. By Sales

                15.8.7.2.4. By Distribution Channel

16. South Asia Market Analysis 2016 to 2022 and Forecast 2023 to 2033

    16.1. Introduction

    16.2. Historical Market Size (US$ Million) Trend Analysis, By Market Taxonomy, 2016 to 2022

    16.3. Current and Future Market Size (US$ Million) Analysis and Forecast, By Market Taxonomy, 2023 to 2033

        16.3.1. By Country

            16.3.1.1. India

            16.3.1.2. Indonesia

            16.3.1.3. Malaysia

            16.3.1.4. Thailand

            16.3.1.5. Rest of South Asia

        16.3.2. By Product

        16.3.3. By Route of Administration

        16.3.4. By Sales

        16.3.5. By Distribution Channel

    16.4. Market Attractiveness Analysis

        16.4.1. By Country

        16.4.2. By Product

        16.4.3. By Route of Administration

        16.4.4. By Sales

        16.4.5. By Distribution Channel

    16.5. Key Market Participants - Intensity Mapping

    16.6. Drivers and Restraints - Impact Analysis

    16.7. Key Market Trends

    16.8. Country-Level Analysis & Forecast

        16.8.1. India Market

            16.8.1.1. Introduction

            16.8.1.2. Market Analysis and Forecast by Market Taxonomy

                16.8.1.2.1. By Product

                16.8.1.2.2. By Route of Administration

                16.8.1.2.3. By Sales

                16.8.1.2.4. By Distribution Channel

        16.8.2. Indonesia Market

            16.8.2.1. Introduction

            16.8.2.2. Market Analysis and Forecast by Market Taxonomy

                16.8.2.2.1. By Product

                16.8.2.2.2. By Route of Administration

                16.8.2.2.3. By Sales

                16.8.2.2.4. By Distribution Channel

        16.8.3. Malaysia Market

            16.8.3.1. Introduction

            16.8.3.2. Market Analysis and Forecast by Market Taxonomy

                16.8.3.2.1. By Product

                16.8.3.2.2. By Route of Administration

                16.8.3.2.3. By Sales

                16.8.3.2.4. By Distribution Channel

        16.8.4. Thailand Market

            16.8.4.1. Introduction

            16.8.4.2. Market Analysis and Forecast by Market Taxonomy

                16.8.4.2.1. By Product

                16.8.4.2.2. By Route of Administration

                16.8.4.2.3. By Sales

                16.8.4.2.4. By Distribution Channel

17. East Asia Market Analysis 2016 to 2022 and Forecast 2023 to 2033

    17.1. Introduction

    17.2. Historical Market Size (US$ Million) Trend Analysis, By Market Taxonomy, 2016 to 2022

    17.3. Current and Future Market Size (US$ Million) Analysis and Forecast, By Market Taxonomy, 2023 to 2033

        17.3.1. By Country

            17.3.1.1. China

            17.3.1.2. Japan

            17.3.1.3. South Korea

        17.3.2. By Product

        17.3.3. By Route of Administration

        17.3.4. By Sales

        17.3.5. By Distribution Channel

    17.4. Market Attractiveness Analysis

        17.4.1. By Country

        17.4.2. By Product

        17.4.3. By Route of Administration

        17.4.4. By Sales

        17.4.5. By Distribution Channel

    17.5. Key Market Participants - Intensity Mapping

    17.6. Drivers and Restraints - Impact Analysis

    17.7. Key Market Trends

    17.8. Country-Level Analysis & Forecast

        17.8.1. China Market

            17.8.1.1. Introduction

            17.8.1.2. Market Analysis and Forecast by Market Taxonomy

                17.8.1.2.1. By Product

                17.8.1.2.2. By Route of Administration

                17.8.1.2.3. By Sales

                17.8.1.2.4. By Distribution Channel

        17.8.2. Japan Market

            17.8.2.1. Introduction

            17.8.2.2. Market Analysis and Forecast by Market Taxonomy

                17.8.2.2.1. By Product

                17.8.2.2.2. By Route of Administration

                17.8.2.2.3. By Sales

                17.8.2.2.4. By Distribution Channel

        17.8.3. South Korea Market

            17.8.3.1. Introduction

            17.8.3.2. Market Analysis and Forecast by Market Taxonomy

                17.8.3.2.1. By Product

                17.8.3.2.2. By Route of Administration

                17.8.3.2.3. By Sales

                17.8.3.2.4. By Distribution Channel

18. Oceania Market Analysis 2016 to 2022 and Forecast 2023 to 2033

    18.1. Introduction

    18.2. Historical Market Size (US$ Million) Trend Analysis, By Market Taxonomy, 2016 to 2022

    18.3. Current and Future Market Size (US$ Million) Analysis and Forecast, By Market Taxonomy, 2023 to 2033

        18.3.1. By Country

            18.3.1.1. Australia

            18.3.1.2. New Zealand

        18.3.2. By Product

        18.3.3. By Route of Administration

        18.3.4. By Sales

        18.3.5. By Distribution Channel

    18.4. Market Attractiveness Analysis

        18.4.1. By Country

        18.4.2. By Product

        18.4.3. By Route of Administration

        18.4.4. By Sales

        18.4.5. By Distribution Channel

    18.5. Key Market Participants - Intensity Mapping

    18.6. Drivers and Restraints - Impact Analysis

    18.7. Key Market Trends

    18.8. Country-Level Analysis & Forecast

        18.8.1. Australia Market

            18.8.1.1. Introduction

            18.8.1.2. Market Analysis and Forecast by Market Taxonomy

                18.8.1.2.1. By Product

                18.8.1.2.2. By Route of Administration

                18.8.1.2.3. By Sales

                18.8.1.2.4. By Distribution Channel

        18.8.2. New Zealand Market

            18.8.2.1. Introduction

            18.8.2.2. Market Analysis and Forecast by Market Taxonomy

                18.8.2.2.1. By Product

                18.8.2.2.2. By Route of Administration

                18.8.2.2.3. By Sales

                18.8.2.2.4. By Distribution Channel

19. Middle East and Africa (MEA) Market Analysis 2016 to 2022 and Forecast 2023 to 2033

    19.1. Introduction

    19.2. Historical Market Size (US$ Million) Trend Analysis, By Market Taxonomy, 2016 to 2022

    19.3. Current and Future Market Size (US$ Million) Analysis and Forecast, By Market Taxonomy, 2023 to 2033

        19.3.1. By Country

            19.3.1.1. GCC Countries

            19.3.1.2. Turkey

            19.3.1.3. South Africa

            19.3.1.4. North Africa

            19.3.1.5. Rest of Middle East and Africa

        19.3.2. By Product

        19.3.3. By Route of Administration

        19.3.4. By Sales

        19.3.5. By Distribution Channel

    19.4. Market Attractiveness Analysis

        19.4.1. By Country

        19.4.2. By Product

        19.4.3. By Route of Administration

        19.4.4. By Sales

        19.4.5. By Distribution Channel

    19.5. Key Market Participants - Intensity Mapping

    19.6. Drivers and Restraints - Impact Analysis

    19.7. Key Market Trends

    19.8. Country-Level Analysis & Forecast

        19.8.1. GCC Countries Market

            19.8.1.1. Introduction

            19.8.1.2. Market Analysis and Forecast by Market Taxonomy

                19.8.1.2.1. By Product

                19.8.1.2.2. By Route of Administration

                19.8.1.2.3. By Sales

                19.8.1.2.4. By Distribution Channel

        19.8.2. Turkey Market

            19.8.2.1. Introduction

            19.8.2.2. Market Analysis and Forecast by Market Taxonomy

                19.8.2.2.1. By Product

                19.8.2.2.2. By Route of Administration

                19.8.2.2.3. By Sales

                19.8.2.2.4. By Distribution Channel

        19.8.3. South Africa Market

            19.8.3.1. Introduction

            19.8.3.2. Market Analysis and Forecast by Market Taxonomy

                19.8.3.2.1. By Product

                19.8.3.2.2. By Route of Administration

                19.8.3.2.3. By Sales

                19.8.3.2.4. By Distribution Channel

        19.8.4. North Africa Market

            19.8.4.1. Introduction

            19.8.4.2. Market Analysis and Forecast by Market Taxonomy

                19.8.4.2.1. By Product

                19.8.4.2.2. By Route of Administration

                19.8.4.2.3. By Sales

                19.8.4.2.4. By Distribution Channel

20. Market Structure Analysis

    20.1. Market Analysis by Tier of Companies

    20.2. Market Share Analysis of Top Players

    20.3. Market Presence Analysis

        20.3.1. Regional footprint of Players

        20.3.2. Platform Type foot print by Players

        20.3.3. Channel Foot Print by Players

21. Competition Analysis

    21.1. Competition Dashboard

    21.2. Competition Benchmarking

    21.3. Competition Deep Dive

        21.3.1. Pfizer Inc.

            21.3.1.1. Company Overview

            21.3.1.2. Product Portfolio

            21.3.1.3. Sales Footprint

            21.3.1.4. Key Financials

            21.3.1.5. SWOT Analysis

            21.3.1.6. Key Developments

            21.3.1.7. Strategy Overview

                21.3.1.7.1. Marketing Strategy

                21.3.1.7.2. Product Strategy

                21.3.1.7.3. Channel Strategy

        21.3.2. Sanofi

            21.3.2.1. Company Overview

            21.3.2.2. Product Portfolio

            21.3.2.3. Sales Footprint

            21.3.2.4. Key Financials

            21.3.2.5. SWOT Analysis

            21.3.2.6. Key Developments

            21.3.2.7. Strategy Overview

                21.3.2.7.1. Marketing Strategy

                21.3.2.7.2. Product Strategy

                21.3.2.7.3. Channel Strategy

        21.3.3. Janssen Pharmaceuticals.

            21.3.3.1. Company Overview

            21.3.3.2. Product Portfolio

            21.3.3.3. Sales Footprint

            21.3.3.4. Key Financials

            21.3.3.5. SWOT Analysis

            21.3.3.6. Key Developments

            21.3.3.7. Strategy Overview

                21.3.3.7.1. Marketing Strategy

                21.3.3.7.2. Product Strategy

                21.3.3.7.3. Channel Strategy

        21.3.4. Bayer AG

            21.3.4.1. Company Overview

            21.3.4.2. Product Portfolio

            21.3.4.3. Sales Footprint

            21.3.4.4. Key Financials

            21.3.4.5. SWOT Analysis

            21.3.4.6. Key Developments

            21.3.4.7. Strategy Overview

                21.3.4.7.1. Marketing Strategy

                21.3.4.7.2. Product Strategy

                21.3.4.7.3. Channel Strategy

        21.3.5. GlaxoSmithKline plc

            21.3.5.1. Company Overview

            21.3.5.2. Product Portfolio

            21.3.5.3. Sales Footprint

            21.3.5.4. Key Financials

            21.3.5.5. SWOT Analysis

            21.3.5.6. Key Developments

            21.3.5.7. Strategy Overview

                21.3.5.7.1. Marketing Strategy

                21.3.5.7.2. Product Strategy

                21.3.5.7.3. Channel Strategy

        21.3.6. Bristol-Myers Squibb and Company

            21.3.6.1. Company Overview

            21.3.6.2. Product Portfolio

            21.3.6.3. Sales Footprint

            21.3.6.4. Key Financials

            21.3.6.5. SWOT Analysis

            21.3.6.6. Key Developments

            21.3.6.7. Strategy Overview

                21.3.6.7.1. Marketing Strategy

                21.3.6.7.2. Product Strategy

                21.3.6.7.3. Channel Strategy

        21.3.7. Teva Pharmaceutical Industries Ltd

            21.3.7.1. Company Overview

            21.3.7.2. Product Portfolio

            21.3.7.3. Sales Footprint

            21.3.7.4. Key Financials

            21.3.7.5. SWOT Analysis

            21.3.7.6. Key Developments

            21.3.7.7. Strategy Overview

                21.3.7.7.1. Marketing Strategy

                21.3.7.7.2. Product Strategy

                21.3.7.7.3. Channel Strategy

        21.3.8. Cardinal Health Inc.

            21.3.8.1. Company Overview

            21.3.8.2. Product Portfolio

            21.3.8.3. Sales Footprint

            21.3.8.4. Key Financials

            21.3.8.5. SWOT Analysis

            21.3.8.6. Key Developments

            21.3.8.7. Strategy Overview

                21.3.8.7.1. Marketing Strategy

                21.3.8.7.2. Product Strategy

                21.3.8.7.3. Channel Strategy

        21.3.9. Perrigo Company.

            21.3.9.1. Company Overview

            21.3.9.2. Product Portfolio

            21.3.9.3. Sales Footprint

            21.3.9.4. Key Financials

            21.3.9.5. SWOT Analysis

            21.3.9.6. Key Developments

            21.3.9.7. Strategy Overview

                21.3.9.7.1. Marketing Strategy

                21.3.9.7.2. Product Strategy

                21.3.9.7.3. Channel Strategy

        21.3.10. Novartis AG

            21.3.10.1. Company Overview

            21.3.10.2. Product Portfolio

            21.3.10.3. Sales Footprint

            21.3.10.4. Key Financials

            21.3.10.5. SWOT Analysis

            21.3.10.6. Key Developments

            21.3.10.7. Strategy Overview

                21.3.10.7.1. Marketing Strategy

                21.3.10.7.2. Product Strategy

                21.3.10.7.3. Channel Strategy

        21.3.11. Sun Pharmaceutical Industries Ltd

            21.3.11.1. Company Overview

            21.3.11.2. Product Portfolio

            21.3.11.3. Sales Footprint

            21.3.11.4. Key Financials

            21.3.11.5. SWOT Analysis

            21.3.11.6. Key Developments

            21.3.11.7. Strategy Overview

                21.3.11.7.1. Marketing Strategy

                21.3.11.7.2. Product Strategy

                21.3.11.7.3. Channel Strategy

        21.3.12. Abbott

            21.3.12.1. Company Overview

            21.3.12.2. Product Portfolio

            21.3.12.3. Sales Footprint

            21.3.12.4. Key Financials

            21.3.12.5. SWOT Analysis

            21.3.12.6. Key Developments

            21.3.12.7. Strategy Overview

                21.3.12.7.1. Marketing Strategy

                21.3.12.7.2. Product Strategy

                21.3.12.7.3. Channel Strategy

        21.3.13. Mallinckrodt Pharmaceuticals

            21.3.13.1. Company Overview

            21.3.13.2. Product Portfolio

            21.3.13.3. Sales Footprint

            21.3.13.4. Key Financials

            21.3.13.5. SWOT Analysis

            21.3.13.6. Key Developments

            21.3.13.7. Strategy Overview

                21.3.13.7.1. Marketing Strategy

                21.3.13.7.2. Product Strategy

                21.3.13.7.3. Channel Strategy

        21.3.14. Procter & Gamble Company

            21.3.14.1. Company Overview

            21.3.14.2. Product Portfolio

            21.3.14.3. Sales Footprint

            21.3.14.4. Key Financials

            21.3.14.5. SWOT Analysis

            21.3.14.6. Key Developments

            21.3.14.7. Strategy Overview

                21.3.14.7.1. Marketing Strategy

                21.3.14.7.2. Product Strategy

                21.3.14.7.3. Channel Strategy

22. Assumptions and Acronyms Used

23. Research Methodology

Recommendations

Healthcare

Acetaminophen API Market

September 2020

REP-GB-12465

July 2023

306 pages

Healthcare

Chronic Obstructive Pulmonary Disease (COPD) Market

December 2022

REP-GB-16215

276 pages

Healthcare

Acute Migraine Treatment Market

April 2019

REP-GB-9324

June 2022

250 pages

Explore Healthcare Insights

View Reports